HealthTech Industry Update
|
|
|
Hello GIANT community member
|
|
The year has barely gotten started and already the HealthTech world is flying ahead. Funding rounds have closed, products launched, and multinational collaborations announced.
2019 is going to be a phenomenal year!
Barry and the GIANT Health team
|
|
HealthTech at CES 2019
Las Vegas hosted CES 2019 this week, and many healthtech apps and devices were on show. Here is just a handful of some of the interesting and innovative products on show.
Flint Rehab, which makes devices to help stroke survivors recover, launched the MiGo, a wearable device designed to help in rehabilitation following a stroke. The MiGo addresses the problem of learned non-use by motivating stroke survivors to use their impaired side as much as possible. It uses gamification to track activity throughout the day, set new goals, and provide encouragement.
The Touchpoint Basic tackles the problem of stress with a pair of wearables that emit vibrations. The bi-lateral stimulation is intended to reduce the physical effects of stress.
|
Chronic pain is usually treated with copious amounts of painkillers. In the US, this has created an opiate addiction crisis, but elsewhere the unwanted side effects from pill-popping are the bane of people's lives. Quell 2.0 is a small device that straps to the leg and delivers mild shocks that disrupt pain signals to provide pain relief. A companion app enables personalisation to help manage treatment.
The Pria from Stanley Black & Decker is a home care companion that provides remote care through audio and video capabilities. The device can also ensure that that the right dose of medication is taken at the right time.
Meanwhile, Diapason from Immersive Therapy, aims to provide relief from tinnitus by retraining misfiring neurons through a series of games.
|
|
|
|
The MiGo from Flint Rehab is designed to help in stroke rehabilitation
|
|
Opportunities for collaboration
|
|
Japan-UK £30 million partnership
Japan and the UK have signed a £30 million collaboration agreement for research in AI and Robotics. £10 million will go towards a joint programme between the UK's Medical Research Council and Japan’s Agency for Medical Research and Development to fund research into critical regenerative processes in human health and translate research into tools and technologies to treat patients.
As part of the programme, a competition will make funding available to businesses, including startups. The focus of the competition will be on the use of AI and robotics in assisted living to help create safe, ethical and intelligent home environments.
EU €30 million call for neurodegenerative disease research
The EU's neurodegenerative disease research initiative, JPND, has announced a €30 million call for multinational research on personalised medicine for neurodegenerative diseases.
JPND is seeking proposals from multinational research teams for ambitious, innovative and multidisciplinary collaborative research projects to change the trajectory of these diseases through the development of precision medicine approaches.
|
|
Fundraising in HealthTech
|
|
SOPHiA GENETICS, Switzerland
- $77 million
- Generation Investment Management, Idinvest Partners, Balderton Capital and Alychlo
The Swiss company's platform, SOPHiA AI, enables healthcare professionals to make sense of complex genomic and radiomic data in order to better diagnose and treat patients, both for oncology and hereditary disorders.
The latest funding round, which brings total investment in the company up to $140 million, will be used to expand its activities, particularly in the US.
|
Vantage Health, India
- $50 million
- IQGEN Holdings LCC
Vantage Health collects and processes diagnostic samples using saliva, and sometimes blood, to collect genetic, microbiome and epigenetic data from users on a regular basis.
The Mumbai-based startup plans to use the funds to support its operations and technology development.
|
|
Care Across is an award-winning digital health company focusing on cancer. It provides patients with 100% personalised digital therapeutics to improve quality of life and medical outcomes, based on peer-reviewed publications and scientific evidence.
Its patient offerings are available in 5 languages (covering EU5 and beyond), and address the majority of cancer cases.
Care Across collaborates with the industry, offering services around Real World Evidence and Patient Reported Outcomes, Patient Support Programmes, Clinical Trial Recruitment and more.
|
|
We're back in London in the autumn to bring together the world's healthech innovators, to make connections, and to forge collaborations.
Tickets go on sale soon.
Mark your diaries!
|
|
|
London, 15-16 October 2019
|
|
|
|
The GIANT Health newsletter reaches HealthTech innovators around the world. Get in contact to discuss partnership opportunities.
|
|
|
|
|
|
